e2se.energy

Fluorescéine — acadpharm

4.6 (456) · € 18.99 · En Stock

WO2014025785A2 - Prion protein ligands as therapeutic agents for neurodegenerative disorders - Google Patents

WO2004064745A2 - Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses - Google Patents

Nanotherapeutics For Drug Targeting INGBER; Donald E. ; et al. [PRESIDENT AND FELLOWS OF HARVARD COLLEGE]

CN102459273A - Methods and compositions for studying, imaging, and treating pain - Google Patents

WO2016090317A1 - Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases - Google Patents

US8765760B2 - [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases - Google Patents

US9359363B2 - Identification of compounds that disperse TDP-43 inclusions - Google Patents

Fluorescéine — acadpharm

US9527815B2 - Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases - Google Patents

US9174999B2 - Methods and compositions for studying, imaging, and treating pain - Google Patents

WO2004064745A2 - Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses - Google Patents

WO2016090317A1 - Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases - Google Patents

WO2016090317A1 - Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases - Google Patents

WO2022056453A1 - Therapeutic conjugates - Google Patents

Methods relating to the diagnosis and treatment of preeclampsia comprising administration of ADAMTS13 polypeptides Patent Grant Wagner , et al. [CHILDREN'S MEDICAL CENTER CORPORATION]